Skip to content

AbCellera Biologics Inc.

ABCL· Nasdaqxbrl foundCIK 1703057

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -2.64%
Market cap
$3.79B
326.62M shares
Filings
329
$10.64M
Q3 2026+160.6% FY25 yoy
-$40.76M
Q3 2026N/M FY25 yoy
-$53.32M
Q3 2026N/M FY25 yoy
$11.74M
Q3 2026derivedN/M FY25 yoy
-$0.13
Q3 2026N/M FY25 yoy
$163.80M
Q3 2026−17.8% FY25 yoy
$3.79B
—
55.9×
3.6×
-0.87%
—

Twelve months to Sep 30, 2026 · derived

Price

$11.62+189.65%+$7.61past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$75.13MFY 2025
$485.42M0FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$75,128,000reported
FY 20242024-12-31$28,833,000reported
FY 20232023-12-31$38,025,000reported
FY 20222022-12-31$485,424,000reported
FY 20212021-12-31$375,203,000reported
FY 20202020-12-31$233,155,000reported
FY 20192019-12-31$11,612,000reported

Segments

Revenue by Geography, FY2021 to FY2025FY2021Canada · FY2021 · $353.40MUnited States · FY2021 · $21.80MFY2022Canada · FY2022 · $484.20MUnited States · FY2022 · $1.20MFY2023Canada · FY2023 · $36.00MUnited States · FY2023 · $2.00MFY2024Canada · FY2024 · $26.20MUnited States · FY2024 · $2.70MFY2025Canada · FY2025 · $64.00MUnited States · FY2025 · $11.10M
LineFY2025ShareChange
Canada$64.00M85%+144.3%
United States$11.10M15%+311.1%
Total$75.13M

From the 10-K filed Feb 24, 2026ABCL

Pharmaceutical preparations

AbCellera Biologics Inc. is the 112th largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

AbCellera Biologics Inc. · CIK 1703057 · Engraved from SEC EDGAR